MIA 2021, Manejo Integral del Asma. Lineamientos para México
Désirée Larenas‐Linnemann, Jorge Salas‐Hernandez, Blanca E. Del-Río-Navarro, Jorge A. Luna‐Pech, Elsy Maureen Navarrete‐Rodríguez, Laura Gochicoa‐Rangel, María del Carmen Cano-Salas, Ulises Noel García‐Ramírez, Erika del Carmen López‐Estrada, José Antonio Ortega‐Martell, Ambrosio Aguilar-Aranda, Sergio Caretta‐Barradas, Martín Bedolla‐Barajas, Robert Camargo, Francisco Cuevas-Schacht, Margarita Fernández-Vega, Carlos García-Bolaños, Claudia Garrido-Galindo, Marcos Alejandro Jiménez-Chobillón, Carlos Juárez-Ortíz, María del Carmen Larios-García, Héctor León‐Molina, Alejandra Macías-Weinmann, Eric Martínez, Norma E. Martínez-Jiménez, Rocío Esmeralda Mateos-Martínez, Jaime Mellado-Ábrego, Víctor Manuel Mendoza-Romero, Carol Vivian Moncayo-Coello, Sergio Monráz-Pérez, Gabriel Montes, Francisco Ignacio Ortiz-Aldana, Carlos Lenin Pliego-Reyes, A. Reyes-Contreras, Irasema Rodríguez-Godínez, Héctor Hernán Ruiz‐Gutiérrez, Andrés Sánchez-González, César F. Segovia-Montero, Saraí del Carmen Toral-Freyre, Jorge Vázquez-García
Abstract
BACKGROUND: Asthma continues to be one of the most frequent chronic respiratory diseases in our country. New methods for diagnosis and treatment have been described; accordingly, the international guidelines were renewed. OBJECTIVE: To create a national platform for the development of updated guidelines, solidly based on evidence: Comprehensive Asthma Management (Spanish acronym: MIA). METHODS: MIA uses the ADAPTE method. The MIA development group consists of experts in pulmonology-allergology-methodology and representatives of 13 institutions and societies of specialties that manage asthma. The international reference guidelines (selected with AGREE-II): GINA 2020, GEMA 5.0, BTS/SIGN 2019 and ATS/ERS consensus document 2014-2019 on severe asthma. MIA covers suspected asthma, diagnosis, treatment, and special groups. Key clinical questions were formulated on treatment steps 1-3, biomarkers and severe asthma. RESULTS: Based on evidence, safety, cost and local reality, the core group developed responses. Through a Delphi process the broad MIA development group suggested adjustments until consensus was reached. CONCLUSION: A document was generated with multiple figures and algorithms, solidly based on evidence about asthma management, adjusted for Mexico with a broad base among different societies that participated in its development. It does not include guidelines for acute asthma.